Resource Centers
Slideshow
- US Preparing for Fall H1N1 Flu Season
- Infectious Mononucleosis May Increase Risk for Chronic Fatigue Syndrome in Teens
- Radiographic Pneumonia Uncommon in Children With Wheezing
- Paternal Depressive Symptoms During Pregnancy May Predict Excessive Infant Crying
- Alert Tissue Retained in Arthroscopic Shavers After Cleaning, FDA Warns
Medscape Journals
Specialty Spotlight
-
Physicians Are Talking About: The Audacity That Physicians Should Take the Helm of Healthcare Reform
-
Crying Babies: How Should They Be Assessed?
-
Effect of Maternal Psychopathology on Behavioral Problems in Preschool Children Exposed to Terrorism
-
Why More Doctors Should Use NPs and PAs -- And Why They Don't
-
Effectiveness of Pneumococcal Pneumonia Vaccine
Medscape Community Resources
- PTH Levels and Cardiovascular Mortality
- Physicians Are Talking About: The Audacity That Physicians Should Take the Helm of Healthcare Reform
- Who's to Blame for Our High Healthcare Costs? Payer, Payee, or Another Culprit?
- Crying Babies: How Should They Be Assessed?
- Determining the Genetic Origin of the 2009 A(H1N1) "Swine" Flu
POLL
A study published last month in the Archives of Internal Medicine reveals primary care practices sometimes do not inform patients of abnormal lab results or do not keep a record of the patient being informed. About 1 of every 14 abnormal tests was not reported to the patient. How likely or not likely is this to happen in your practice?
- A treatment option for ACS and DVT/PE
- ABILIFY® (aripiprazole)
- ACTONEL® (risedronate sodium tablets)
- ACUVUE® Brand Contact Lenses
- Atrial Fibrillation Condition Site
- COSAMIN®DS
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- EPZICOM® (abacavir sulfate and lamivudine) Tablets
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEMZAR® (gemcitabine HCI)
- GEODON® (ziprasidone HCI)
- Genomic Advances in Cardiovascular Care
- Heartmate II® Left Ventricular Assist System
- ISENTRESS® (raltegravir) Tablets
- Iron Toxicity InfoSite
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NUCYNTA™ (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- Navigenics® Genetic Risk Assessment Services
- OPTIMAL Forum™
- PEGASYS (peginterferon alfa-2a) for injection
- PREMARIN® (conjugated estrogens tablets, USP)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- REBIF® (interferon beta-1a)
- Reclast® (zoledronic acid) injection
- Survivorship and Early Breast Cancer Information
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- Talecris Hypermunes™
- Targeted Biologic Therapy in Breast Cancer
- Targeting CD20: Scientific Insights and Implications for Therapy
- The Pain Institute
- The Threat and Scope of Distant Metastases in Early Breast Cancer
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
